Combined assessment of carotid vulnerable plaque, renal insufficiency, eosinophilia, and hs-CRP for predicting risky aortic plaque of cholesterol crystal embolism

Circulation Journal

Volumn 74, Issue 1, 2010, Pages 51-58

  Machino Ohtsuka, Tomoko ^a   Seo, Yoshihiro ^a   Ishizu, Tomoko ^a   Sekiguchi, Yukio ^a   Sato, Akira ^a   Tada, Hiroshi ^a   Watanabe, Shigeyuki ^a   Aonuma, Kazutaka ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Carotid plaque; Cholesterol embolism; Eosinophilia; hs CRP; Renal insufficiency

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; AGED; AORTA ATHEROSCLEROSIS; ARTICLE; CAROTID ARTERY DISEASE; CAROTID ARTERY PLAQUE; CHOLESTEROL EMBOLISM; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYSLIPIDEMIA; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PREDICTOR VARIABLE; PROSPECTIVE STUDY; RISK FACTOR; SCREENING;

AGED; AGED, 80 AND OVER; AORTIC DISEASES; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CAROTID STENOSIS; CRYSTALLIZATION; EMBOLISM, CHOLESTEROL; EOSINOPHILIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 75149112731     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0526     Document Type: Article

References (30)

1. Fukumoto Y, Tsutsui H, Tsuchihashi M, Masumoto A, Takeshita A. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: A prospective study. J Am Coll Cardiol 2003; 42: 211-216.
2. Scolari F, Bracchi M, Valzorio B, Movilli E, Costantino E, Savoldi S, et al. Cholesterol atheromatous embolism: An increasingly recognized cause of acute renal failure. Nephrol Dial Transplant 1996; 11: 1607-1612.
3. Gaspar M, Laufer G, Bonatti J, Muller L, Mair P. Epiaortic ultrasound and intraoperative transesophageal ecocardiography for the thoracic aorta atherosclerosis assessment in patient undergoing CABG: Surgical technique modification to avoid cerebral stroke. Chirurgia (Bucur) 2002; 97: 529-535.
4. Hagiwara N, Toyoda K, Nakayama M, Inoue T, Yasumori K, Ibayashi S, et al. Renal cholesterol embolism in patients with carotid stenosis: A severe and underdiagnosed complication following cerebrovascular procedures. J Neurol Sci 2004; 222: 109-112.
5. El Idrissi R, El Ounani F, El Khloufi S, Martin S, Bensaid Y, Clement C. Facial cutaneous cholesterol embolism revealing a tight carotid stenosis: A case report. Eur J Vasc Endovasc Surg 2007; 33: 62-64.
6. Funabiki K, Masuoka H, Shimizu H, Emi Y, Mori T, Ito M, et al. Cholesterol crystal embolization (CCE) after cardiac catheterization: A case report and a review of 36 cases in the Japanese literature. Jpn Heart J 2003; 44: 767-774.
7. Fazio GP, Redberg RF, Winslow T, Schiller NB. Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease. J Am Coll Cardiol 1993; 21: 144-150.
8. Triposkiadis F, Sitafidis G, Kostoulas J, Skoularigis J, Zintzaras E, Fezoulidis I. Carotid plaque composition in stable and unstable coronary artery disease. Am Heart J 2005; 150: 782-789.
9. Detrano R, Yiannikas J, Salcedo EE, Rincon G, Go RT, Williams G, et al. Bayesian probability analysis: A prospective demonstration of its clinical utility in diagnosing coronary disease. Circulation 1984; 69: 541-547.
10. Izumi C, Kondo H, Tamura T, Inoko M, Kitaguchi S, Himura Y, et al. Clinical evaluation of cholesterol embolization syndrome after cardiac catheterization. J Cardiol 1998; 31: 201-206 (in Japanese).
11. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843.
12. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979.
13. Matsushita K, Yatsuya H, Tamakoshi K, Yang PO, Otsuka R, Wada K, et al. High-sensitivity C-reactive protein is quite low in Japanese men at high coronary risk. Circ J 2007; 71: 820-825.
14. Shimada K, Fujita M, Tanaka A, Yoshida K, Jisso S, Tanaka H, et al. Elevated serum C-reactive protein levels predict cardiovascular events in the Japanese coronary artery disease (JCAD) study. Circ J 2009; 73: 78-85.
15. Ridker PM. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-1818.
16. Prentice RL, Szatrowski TP, Fujikura T, Kato H, Mason MW, Hamilton HH. Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol 1982; 116: 496-509.
17. Sweetnam PM, Thomas HF, Yarnell JW, Baker IA, Elwood PC. Total and differential leukocyte counts as predictors of ischemic heart disease: The Caerphilly and Speedwell studies. Am J Epidemiol 1997; 145: 416-421.
18. Siddiqui S, MacGregor MS, Glynn C, Roditi G, Deighan CJ. Factors predicting outcome in a cohort of patients with atherosclerotic renal artery disease diagnosed by magnetic resonance angiography. Am J Kidney Dis 2005; 46: 1065-1073.
19. Parikh NI, Hwang SJ, Larson MG, Levy D, Fox CS. Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol 2008; 102: 47-53.
20. Furukawa Y, Ehara N, Taniguchi R, Haruna Y, Ozasa N, Saito N, et al. Coronary risk factor profile and prognostic factors for young Japanese patients undergoing coronary revascularization. Circ J 2009; 73: 1459-1465.
21. Tanaka M, Matsuo K, Shoda H, Takami S, Naruse M, Matsuyama K. Severe hyperreninemic hypertension associated with spontaneous renal cholesterol crystal embolization. Clin Exp Nephrol 2004; 8: 150-154.
22. Moolenaar W, Lamers CB. Cholesterol crystal embolization in the Netherlands. Arch Intern Med 1996; 156: 653-657.
23. Honda O, Sugiyama S, Kugiyama K, Fukushima H, Nakamura S, Koide S, et al. Echolucent carotid plaques predict future coronary events in patients with coronary artery disease. J Am Coll Cardiol 2004; 43: 1177-1184.
24. Khoury Z, Gottlieb S, Stern S, Keren A. Frequency and distribution of atherosclerotic plaques in the thoracic aorta as determined by transesophageal echocardiography in patients with coronary artery disease. Am J Cardiol 1997; 79: 23-27.
25. Okuyama T, Ehara S, Shirai N, Sugioka K, Yamashita H, Kataoka T, et al. Assessment of aortic atheromatous plaque and stiffness by 64-slice computed tomography is useful for identifying patients with coronary artery disease. Circ J 2008; 72: 2021-2027.
26. Sanai T, Matsui R, Hirano T. LDL apheresis for cholesterol embolism following coronary artery bypass graft surgery: A case report. Angiology 2006; 57: 379-382.
27. Saito T. Corticosteroid pulse the therapy for the treatment of cholesterol embolic disease. Intern Med 2003; 42: 1159-1160.
28. Rumpf KW, Schult S, Mueller GA. Simvastatin treatment in cholesterol emboli syndrome. Lancet 1998; 352: 321-322.
29. Grenader T, Lifschitz M, Shavit L. Iloprost in embolic renal failure. Mt Sinai J Med 2005; 72: 339-341.
30. Orr WP, Banning AP. Aortic atherosclerotic debris detected by trans-oesophageal echocardiography: A risk factor for cholesterol embolization. Q J Med 1999; 92: 341-346.